Feasibility of hippocampal dose-volume parameters associated with memory decline in intensity-modulated radiotherapy for supratentorial tumors

The purpose of the present retrospective study was to evaluate the feasibility of hippocampal dose-volume parameters associated with memory decline for intensity-modulated radiotherapy (IMRT). In total, 18 patients who underwent IMRT for supratentorial tumors were analyzed. Prescribed doses of IMRT...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular and clinical oncology 2021-03, Vol.14 (3), p.53-53, Article 53
Hauptverfasser: Takahashi, Shigeo, Anada, Masahide, Kinoshita, Toshifumi, Nishide, Takamasa, Kozai, Shohei, Shibata, Toru
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The purpose of the present retrospective study was to evaluate the feasibility of hippocampal dose-volume parameters associated with memory decline for intensity-modulated radiotherapy (IMRT). In total, 18 patients who underwent IMRT for supratentorial tumors were analyzed. Prescribed doses of IMRT in 30 fractions were 60 Gy to planning target volume (PTV) 1 of the local area and 48-51 Gy to PTV2 of the extended local area. Based on previous literature, the present study investigated dose-volume parameters of the bilateral hippocampi: D of 13.1 Gy, D of 29.6 Gy, and V of 5.0%. It was evaluated which of the parameters was most achievable, and unfavorable factors that interfere with reaching these parameters were identified. As a result, D of 13.1 Gy, D of 29.6 Gy and V of 5.0% were achieved in 17, 67 and 33% of patients, respectively. For D of 29.6 Gy, PTV2 ≥500 cc (P=0.004) and tumor in temporal/corpus callosum/basal ganglia (P=0.009) were significant unfavorable factors. In conclusion, D of 29.6 Gy was most achievable. In daily clinical practice, it should be primarily attempted to achieve D of 29.6 Gy of the bilateral hippocampi.
ISSN:2049-9450
2049-9469
DOI:10.3892/MCO.2021.2215